ANDA 214513, held by Laurus. Atorvastatin Calcium.
As of Nov 16, 2026, ANDA 214513 (Atorvastatin Calcium), held by Laurus, was first approved by FDA on Jan 22, 2024, with 0 approved supplements and 0 published complete response letters.
Atorvastatin calcium tablets are indicated:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jan 22, 2024 | Original application | Approved | None posted |
| Atorvastatin CalciumEQ 10MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 20MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 40MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
| Atorvastatin CalciumEQ 80MG BASE · tablet;oral | Atorvastatin Calcium | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters